Pharmaceutical - Aspen Pharmacare


Current filters:

Aspen Pharmacare

Popular Filters

GlaxoSmithKline agrees £700 million deal with Aspen

GlaxoSmithKline agrees £700 million deal with Aspen


GlaxoSmithKline says it has now reached agreement to sell its thrombosis brands, Arixtra and Fraxiparine,…

ArixtraAspen PharmacareCardio-vascularFraxiparineGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalRest of the World

Aspen Pharma reports rise in profits from new product launches


South Africa's leading drugmaker Aspen Pharmacare (APN: SJ) has released financial results which show…

ArixtraAspen PharmacareFinancialFraxiparineGlaxoSmithKlineMerck & CoPharmaceuticalRest of the World

Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site


UK pharma giant GlaxoSmithKline (LSE: GSK) said yesterday (June 18) that it has received an offer for…

ArixtraAspen PharmacareCardio-vascularFraxiparineGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalProduction

South Africa's drugmakers bemoan low medicine price hikes


South Africa's Department of Health announced last week that pharmaceutical companies will be allowed…

Adcock IngramAspen PharmacareGenericsPharmaceuticalPricingRest of the World

Aspen Pharmacare acquires portfolio from GSK in Australia for £172 million


South Africa headquartered Aspen Pharmacare (APN: SJ) revealed this morning that it has reached agreement…

Asia-PacificAspen PharmacareGlaxoSmithKlineMergers & AcquisitionsPharmaceutical

Company Spotlight



Back to top